Furthermore, dysregulation of IGF-1 signaling emerged as a central mechanism, with decreased circulating IGF-1 levels and impaired cardiac IGF-1 signaling contributing to obesity, insulin resistance, and systemic metabolic syndrome. This evidence concerns the gene IGF1 and obesity disorder.